April 11th 2022
A panel of expert discuss interstitial lung disease (ILD) in depth, from definition to the best possible therapy options for treatment.
March 25th 2022
A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.
February 16th 2022
A panel of clinicians and managed care decision makers describe how to best refer to real-world evidence when making treatment decisions for patients with multiple myeloma.
December 23rd 2021
Payer and clinician insight regarding the integration of comprehensive genomic profiling into routine clinical practice to help oncologists make more informed treatment decisions for patients with cancer.
December 21st 2021
Expert panelists provide an overview of the burden of MDS, review currently available treatment options, and explore the clinical and payer considerations of oral treatments.
December 21st 2021
Jim Kenney, RPh, MBA; Kevin U. Stephens, Sr, JD, MD; Philip Niles, MD, MBA; and Nicholas G. Anderson, MD, review the clinical and economic burden of wet AMD and diabetic macular edema (DME), share currently available treatment options, and discuss considerations for emerging ophthalmic therapies.
December 20th 2021
Neil Minkoff, MD, provides a glimpse at an upcoming Peer Exchange featuring a panel of clinicians and managed care decision makers for a discussion on women’s reproductive health.
December 17th 2021
This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.